Indoco Remedies promoters buy 10,000 shares via open market
- Promoters Aditi M. Panandikar and Madhura Suresh Kare acquired a combined 10,000 equity shares of Indoco Remedies from the open market on August 28 and 31, 2026.
- Each promoter acquired 5,000 shares, representing 0.01% of total share and voting capital.
- Combined promoter holding rose from 53,96,671 shares (5.85%) to 54,06,671 shares (5.86%) post acquisition.
- The acquisition was disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
- Indoco Remedies equity share capital remains at ₹18,46,07,210/-, divided into 9,23,03,605 equity shares of ₹2/- each.
*this image is generated using AI for illustrative purposes only.
Indoco Remedies promoters Aditi M. Panandikar and Madhura Suresh Kare acquired a combined 10,000 equity shares from the open market on August 28 and 31, 2026, as disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Acquisition details
Each promoter acquired 5,000 equity shares, representing 0.01% of the total share and voting capital of Indoco Remedies. The disclosure was filed by Aditi M. Panandikar for herself and on behalf of Madhura Suresh Kare. Both acquirers belong to the promoter group of the company.
Shareholding before and after acquisition
The table below captures the individual and combined holdings of the two promoters before and after the transaction.
| Promoter | Shares before acquisition | % before | Shares acquired | Shares after acquisition | % after |
|---|---|---|---|---|---|
| Aditi M. Panandikar | 29,17,158 | 3.16 | 5,000 | 29,22,158 | 3.17 |
| Madhura Suresh Kare | 24,79,513 | 2.69 | 5,000 | 24,84,513 | 2.69 |
| Combined total | 53,96,671 | 5.85 | 10,000 | 54,06,671 | 5.86 |
Neither promoter holds any shares in the nature of encumbrance, voting rights otherwise than by equity shares, or warrants or convertible securities, either before or after the acquisition.
Company share capital
The equity share capital of Indoco Remedies remains unchanged at ₹18,46,07,210/-, divided into 9,23,03,605 equity shares of ₹2/- each, both before and after the acquisition. The total diluted share and voting capital of the company is likewise unchanged at ₹18,46,07,210/-, divided into 9,23,03,605 equity shares of ₹2/- each.
The shares of Indoco Remedies are listed on BSE Limited and the National Stock Exchange of India Limited.
Historical Stock Returns for Indoco Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.07% | +11.10% | +10.95% | +20.39% | -8.66% | -49.24% |
Does this open market acquisition signal increased promoter confidence in Indoco Remedies' upcoming financial performance or pipeline developments?
How might this incremental stake increase influence short-term trading volume and price volatility on the BSE and NSE?
Are there indications that these acquisitions are part of a larger strategy to consolidate promoter holding ahead of potential corporate actions or restructuring?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
